1. Atezolizumab: risk of severe cutaneous adverse reactions

   News item 03 July 2021 Pages: 1 - 1

2. Co-codamol batch recall due to homogeneity issue

   News item 03 July 2021 Pages: 2 - 2

3. Interstitial lung disease or pneumonitis with CDK 4/6 inhibitors

   News item 03 July 2021 Pages: 3 - 3

4. Myocarditis or pericarditis following COVID-19 vaccination

   News item 03 July 2021 Pages: 4 - 4

5. Revisions of precautions and ADRs for monoclonal antibodies

   News item 03 July 2021 Pages: 5 - 5

6. Vapours from alcohol-based sanitisers can cause side effects

   News item 03 July 2021 Pages: 6 - 6

7. Antibacterial prescribing increases risk of C. difficile infection

   Clinical study 03 July 2021 Pages: 7 - 7

8. Immune checkpoint inhibitor-related heart disorders

   Clinical study 03 July 2021 Pages: 8 - 8

9. Mirtazapine-related risk of hypothyroxinaemia

   Clinical study 03 July 2021 Pages: 9 - 9

10. Patient-centred web-based ADR reporting system valuable pharmacovigilance tool

    Clinical study 03 July 2021 Pages: 10 - 10

11. Thrombocytopenic purpura with AstraZeneca but not Pfizer-BioNTech COVID-19 vaccine

    Unknown 03 July 2021 Pages: 11 - 11

12. Correction to: Adalimumab: Paradoxical clinically amyopathic dermatomyositis and interstitial lung disease: case report

    Unknown 03 July 2021 Pages: 12 - 12

13. Other adverse reaction research

    News item 03 July 2021 Pages: 13 - 13

14. Acenocoumarol

    Case report 03 July 2021 Pages: 14 - 14

15. Aciclovir/azithromycin/flucloxacillin

    Case report 03 July 2021 Pages: 15 - 15

16. Aciclovir/dexamethasone/doxycycline

    Case report 03 July 2021 Pages: 16 - 16

17. Acitretin/ciclosporin/corticosteroids

    Case report 03 July 2021 Pages: 17 - 17

18. Adalimumab

    Case report 03 July 2021 Pages: 18 - 18

19. Adalimumab

    Case report 03 July 2021 Pages: 19 - 19

20. Adalimumab

    Case report 03 July 2021 Pages: 20 - 20

21. Adalimumab

    Case report 03 July 2021 Pages: 21 - 21

22. Aflibercept

    Case report 03 July 2021 Pages: 22 - 22

23. Agalsidase-beta

    Case report 03 July 2021 Pages: 23 - 23

24. Alcohol

    Case report 03 July 2021 Pages: 24 - 24

25. Alemtuzumab

    Case report 03 July 2021 Pages: 25 - 25

26. Alendronic acid

    Case report 03 July 2021 Pages: 26 - 26

27. Allopurinol

    Case report 03 July 2021 Pages: 27 - 27

28. Allopurinol/methylprednisolone

    Case report 03 July 2021 Pages: 28 - 28

29. Almotriptan abuse overdose

    Case report 03 July 2021 Pages: 29 - 29

30. Alteplase

    Case report 03 July 2021 Pages: 30 - 30

31. Amikacin/cotrimoxazole/imipenem

    Case report 03 July 2021 Pages: 31 - 31

32. Amiodarone

    Case report 03 July 2021 Pages: 32 - 32

33. Amiodarone

    Case report 03 July 2021 Pages: 33 - 33

34. Amiodarone

    Case report 03 July 2021 Pages: 34 - 34

35. Amiodarone

    Case report 03 July 2021 Pages: 35 - 35

36. Amiodarone

    Case report 03 July 2021 Pages: 36 - 36

37. Amiodarone

    Case report 03 July 2021 Pages: 37 - 37

38. Amiodarone

    Case report 03 July 2021 Pages: 38 - 38

39. Amiodarone

    Case report 03 July 2021 Pages: 39 - 39

40. Amiodarone/esmolol/lidocaine

    Case report 03 July 2021 Pages: 40 - 40

41. Amlodipine/hydrochlorothiazide/valsartan

    Case report 03 July 2021 Pages: 41 - 41

42. Amoxicillin overdose

    Case report 03 July 2021 Pages: 42 - 42

43. Amoxicillin/clavulanic-acid

    Case report 03 July 2021 Pages: 43 - 43

44. Amoxicillin/ibuprofen

    Case report 03 July 2021 Pages: 44 - 44

45. Amphotericin-b-liposomal/prednisone/tacrolimus

    Case report 03 July 2021 Pages: 45 - 45

46. Anagrelide

    Case report 03 July 2021 Pages: 46 - 46

47. Antibacterials

    Case report 03 July 2021 Pages: 47 - 47

48. Antidepressants

    Case report 03 July 2021 Pages: 48 - 48

49. Antiepileptic drugs

    Case report 03 July 2021 Pages: 49 - 49

50. Antifungals/antineoplastics

    Case report 03 July 2021 Pages: 50 - 50